Secondary Antifungal Prophylaxis in Hematopoietic Stem Cell Transplantation (HSCT)/Acute Leukemia Patients.

about

Fungal pathogens and primary antifungal prophylaxis in patients with hematological malignancies: one year experience.Weekly high-dose liposomal amphotericin B for secondary prophylaxis of invasive fungal disease in immunocompromised children: experience from a pediatric case series

P2860

Q36569874-00815D8F-ED69-40B9-A51A-2136A2B9B3F8 Q54265693-9AD4EB12-33EE-4186-89BA-07EE5C1569D4

P2860

Secondary Antifungal Prophylaxis in Hematopoietic Stem Cell Transplantation (HSCT)/Acute Leukemia Patients.

Item

http://www.wikidata.org/entity/Q37935599

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Secondary Antifungal Prophylax ...... HSCT)/Acute Leukemia Patients.

@en

Secondary Antifungal Prophylaxis in Hematopoietic Stem Cell Transplantation

@nl

type

Item

label

Secondary Antifungal Prophylax ...... HSCT)/Acute Leukemia Patients.

@en

Secondary Antifungal Prophylaxis in Hematopoietic Stem Cell Transplantation

@nl

prefLabel

Secondary Antifungal Prophylax ...... HSCT)/Acute Leukemia Patients.

@en

Secondary Antifungal Prophylaxis in Hematopoietic Stem Cell Transplantation

@nl

P1476

Secondary Antifungal Prophylax ...... HSCT)/Acute Leukemia Patients.

@en

P2093

Jean El Cheikh

http://www.w3.org/2001/XMLSchema#string

P2860

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia

Efficacy of caspofungin and itraconazole as secondary antifungal prophylaxis: analysis of data from a multinational case registry.

Pharmacokinetics and safety of a unilamellar liposomal formulation of amphotericin B (AmBisome) in rabbits.

Safety, tolerance, and pharmacokinetics of high-dose liposomal amphotericin B (AmBisome) in patients infected with Aspergillus species and other filamentous fungi: maximum tolerated dose study.

Voriconazole for secondary prophylaxis of invasive fungal infections in allogeneic stem cell transplant recipients: results of the VOSIFI study.

Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease.

Impact of the intensity of the pretransplantation conditioning regimen in patients with prior invasive aspergillosis undergoing allogeneic hematopoietic stem cell transplantation: A retrospective survey of the Infectious Diseases Working Party of th

Clinical issues regarding relapsing aspergillosis and the efficacy of secondary antifungal prophylaxis in patients with hematological malignancies.

Safety of a weekly high dose of liposomal amphotericin B for prophylaxis of invasive fungal infection in immunocompromised patients: PROPHYSOME Study.

P304

528-535

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11908-011-0214-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21931981

http://www.w3.org/2001/XMLSchema#string

Secondary Antifungal Prophylaxis in Hematopoietic Stem Cell Transplantation (HSCT)/Acute Leukemia Patients.

about

P2860

P2860

Secondary Antifungal Prophylaxis in Hematopoietic Stem Cell Transplantation (HSCT)/Acute Leukemia Patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698